Bioequivalence Study of Cephalexin Suspension 250
NCT01767571
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Infections, Respiratory Tract
Interventions
DRUG:
Cephalexin 125 mg/5ml
DRUG:
Cephalexin 250mg/5ml
Sponsor
GlaxoSmithKline